DiaSorin launches with CE mark the LIAISON® SARS-CoV-2 Ag, a new high-throughput antigen test for COVID-19 detection in symptomatic patients

Protocollo

86272

Comunicato

Azienda

DIASORIN

Tipo

Comunicato

SDIR

SDIRNIS

Lingua

ENG

Data creazione

Ven, 10/30/2020 - 18:24

Data ricezione SDIR

Lun, 10/26/2020 - 19:30

Data embargo SDIR

Lun, 10/26/2020 - 19:30

Data diffusione SDIR

Ven, 10/30/2020 - 18:22

Mercato

Euronext Milan